Indication
Nasal polyp
A nasal polyp is a benign, soft, noncancerous outgrowth arising from the mucosal lining of the nasal cavity or paranasal sinuses, most frequently emerging from the ethmoid sinuses and middle meatus. Read more about Nasal polyp
2 drugs 2 manufacturers
Drugs that treat it
Common Nasal polyp therapies.
SINUVA (mometasone furoate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA nasal polyp is a benign, soft, noncancerous outgrowth arising from the mucosal lining of the nasal cavity or paranasal sinuses, most frequently emerging from the ethmoid sinuses and middle meatus.
This condition affects the respiratory tract and most commonly develops in adults, particularly in individuals with chronic rhinosinusitis, persistent asthma, aspirin-exacerbated respiratory disease, or cystic fibrosis.
Pathophysiologically, polyps represent the consequence of chronic mucosal inflammation, typically characterized by epithelial barrier disruption, prominent tissue eosinophilia, and stromal edema.
Clinically, these growths appear as pale, semi-translucent masses that can obstruct sinus ostia and nasal airways, leading to progressive nasal congestion, rhinorrhea, facial pressure, and hyposmia or anosmia.
- nih.gov
A nasal polyp is a benign, soft, noncancerous outgrowth arising from the mucosal lining of the nasal cavity or paranasal sinuses, most frequently emerging from the ethmoid sinuses and middle meatus
- nih.gov
A nasal polyp is a benign, soft, noncancerous outgrowth arising from the mucosal lining of the nasal cavity or paranasal sinuses, most frequently emerging from the ethmoid sinuses and middle meatus This condition affects the respiratory tract and most commonly develops in adults, particularly in individuals with chronic rhinosinusitis, persistent asthma, aspirin-exacerbated respiratory disease, or cystic fibrosis Pathophysiologically, polyps represent the consequence of chronic mucosal inflammat...
- nih.gov
This condition affects the respiratory tract and most commonly develops in adults, particularly in individuals with chronic rhinosinusitis, persistent asthma, aspirin-exacerbated respiratory disease, or cystic fibrosis Clinically, these growths appear as pale, semi-translucent masses that can obstruct sinus ostia and nasal airways, leading to progressive nasal congestion, rhinorrhea, facial pressure, and hyposmia or anosmia
- mayoclinic.org
This condition affects the respiratory tract and most commonly develops in adults, particularly in individuals with chronic rhinosinusitis, persistent asthma, aspirin-exacerbated respiratory disease, or cystic fibrosis
- nih.gov
Pathophysiologically, polyps represent the consequence of chronic mucosal inflammation, typically characterized by epithelial barrier disruption, prominent tissue eosinophilia, and stromal edema
- cedars-sinai.org
Clinically, these growths appear as pale, semi-translucent masses that can obstruct sinus ostia and nasal airways, leading to progressive nasal congestion, rhinorrhea, facial pressure, and hyposmia or anosmia
Personalize your experience
Follow Nasal polyp and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.